Nicolas Favre
Chief Business Officer, Business Development & Commercial at Debiopharm Innovation Fund
About
Chief Business Officer overseeing Commercial and Business Development. He joined Debiopharm in 2016 and previously held R&D and marketing roles at Merck Serono, Lundbeck and Novo Nordisk. He holds a PhD from the University of Geneva and an MBA.
Colleagues at Debiopharm Innovation Fund
Angela Zubel
Chief Development Officer, Research & Development at Debiopharm Innovation Fund
Bertrand Ducrey
Chief Executive Officer, Debiopharm International & Senior Vice-Chairman, Debiopharm at Debiopharm Innovation Fund
Cedric Odje
Investment Associate at Debiopharm Innovation Fund
Frédéric Lévy
Chief Scientific Officer, Search & Evaluation and Scientific Innovation at Debiopharm Innovation Fund
Marc Cikes
Managing Director at Debiopharm Innovation Fund
Nicolas Stalder
Senior Investment Associate at Debiopharm Innovation Fund
Pierre Jullian
Chief Finance Officer, Finance, HR, IT & Administration at Debiopharm Innovation Fund
Thierry Mauvernay
President, Delegate of the Board, Debiopharm International SA at Debiopharm Innovation Fund